Core Viewpoint - Bavarian Nordic A/S is undergoing a voluntary public takeover offer from Innosera ApS, backed by Nordic Capital Fund XI and Permira, with the Board of Directors recommending shareholders accept the offer as it presents immediate and attractive value [1][2]. Company Overview - Bavarian Nordic has evolved into a leading vaccine company since 2018, receiving multiple unsolicited inquiries for potential takeover bids [2]. - The company specializes in innovative vaccines, including mpox and smallpox vaccines, and has a strong portfolio of travel vaccines [4]. Offer Details - The Board of Directors has conducted a thorough analysis of the takeover offer, considering the company's financials, performance, and future prospects [2]. - The offer is positioned as an opportunity for shareholders to realize immediate value, which the Board finds attractive [2]. - The Board Statement regarding the offer is available in both Danish and English, with the Danish version prevailing in case of discrepancies [2][3]. Communication and Availability - Offer-related documents, including the Board Statement, are accessible on Bavarian Nordic's website, with notifications sent to registered shareholders [3].

Core Viewpoint - Kenmare Resources plc has terminated discussions regarding a potential offer from a consortium led by Oryx Global Partners Limited, citing that the proposals significantly undervalued the company and its prospects [3][12]. Company Overview - Kenmare Resources plc is a leading global producer of titanium minerals and zircon, operating the Moma Titanium Minerals Mine in northern Mozambique [3]. - The company is confident in its independent prospects and ability to achieve strategic and operational objectives, with a strong order book for the second half of 2025 [5]. Offer Discussions - Initial discussions began on March 6, 2025, when Kenmare received a non-binding proposal from the consortium for an all-cash offer at a price of 530 pence per share [7]. - The Board of Kenmare unanimously rejected the initial proposal, deeming it to undervalue the company [8]. - Subsequent engagement with the consortium revealed that they were only willing to proceed with an offer at a price substantially below the initial proposal, which was also rejected by the Board [11]. Future Plans - Kenmare is progressing with the Wet Concentrator Plant A upgrade project, with commissioning expected to begin in Q3 2025 [6]. - Ongoing discussions with the Government of Mozambique regarding the extension of the Implementation Agreement highlight the company's commitment to its investments and future plans in the region [7].

Core Viewpoint - Nykredit has successfully completed its takeover offer for Spar Nord, acquiring a significant majority of shares and voting rights, and plans to initiate compulsory acquisition of remaining shares [3][4][6]. Group 1: Takeover Offer Details - The offer period for Nykredit's takeover of Spar Nord expired on 20 May 2025, with preliminary results announced on 21 May 2025 [2]. - Nykredit received acceptances for 72,169,763 Spar Nord shares, equating to 94.15% of the total share capital and voting rights, leading to a total holding of 96.54% post-offer [3]. - All relevant public authority approvals have been obtained, confirming that the minimum acceptance condition has been met [4]. Group 2: Completion and Settlement - The completion and settlement of the offer will occur as per the terms outlined in the offer document, with cash payments expected to be made to shareholders on 28 May 2025 [5]. - Following the completion of the offer, Nykredit will seek to initiate a compulsory acquisition of shares held by minority shareholders [6]. Group 3: Delisting Plans - Nykredit intends to request the delisting of Spar Nord shares from Nasdaq Copenhagen A/S after acquiring over 90% of the share capital and voting rights [7].